Hemodialysis and PeritonealDialysis Market Regional Analysis
North America Hemodialysisand Peritoneal Dialysis Market is expected to hold dominant position in theglobal market over the forecast period. Presence of leading manufacturers aswell as increasing number of dialysis procedures is expected to support globalhemodialysis and peritoneal dialysis market growth. According to NationalInstitute of Diabetes and Digestive and Kidney Diseases (NIDDK), over 661,000people in the U.S. had kidney failure and of these, 468,000 individuals were ondialysis, 2017. These factors have supported the North America hemodialysis andperitoneal dialysis market growth.
Dialysis therapy includeshemodialysis to purify the blood using an artificial kidney (dialyzer) andperitoneal dialysis to purify the blood through one's own peritonea. There aretwo types of dialysis which are hemodialysis and peritoneal dialysis.Hemodialysis involves purification of the blood by removing waste products andextra fluid with the help of dialyzer membrane and the purified blood isreturned into the body. Peritoneal dialysis involves purification of the bloodby using the patient's own peritoneum as a dialysis membrane. Patients withchronic kidney diseases are generally kept on dialysis and normal kidneyfunction can only be achieved through kidney transplantation.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2327
Hemodialysis and PeritonealDialysis Market Drivers
Global hemodialysis andperitoneal dialysis market growth is expected to be driver by innovativeproduct launches by leading manufacturers, mergers and acquisitions, andinitiatives by manufacturers to sustain and compete in global hemodialysis andperitoneal dialysis market. For instance, leading manufacturers such asFresenius Medical Care AG & Co. KGaA are focusing on product launches aswell as merger and acquisitions. Fresenius Medical Care supported therecommendation by the National Institute for Health and Care Excellence (NICE)to facilitate population healthcare management for UK patients with end-stagerenal disease by using hemodiafiltration (HDF) rather than high-fluxhemodialysis (HD) in October 2018. This is expected to boost globalhemodialysis and peritoneal dialysis market growth over the forecast period.
Moreover, Fresenius Medical Careand Humacyte, Inc. entered into a strategic partnership in November 2018.Humacyte has developed HUMACYL, which is currently being investigated forvascular access for hemodialysis. Moreover, in April 2018, Fresenius MedicalCare won the Red Dot Award: Product Design for the company’s 6008 CAREsetbloodline system used in hemodialysis. Furthermore, Fresenius Medical Caresigned an agreement to acquire NxStage Medical, Inc., (NxStage), a U.S.-basedmedical technology and Services Company in 2017. B. Braun Medical, Inc. signedan agreement to acquire the bloodlines business operated under the Medisystemsname by NxStage Medical, Inc. In 2017 NxStage Medical, Inc. announced that theU.S. Food and Drug Administration (FDA) cleared its System One for solo homehemodialysis. These factors are expected to support global hemodialysis andperitoneal dialysis market growth over the forecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/hemodialysis-and-peritoneal-dialysis-market-2327
Stringent regulatory policies forthe approval and manufacturing, reimbursement, and risks and complicationsassociated with dialysis treatment are expected to restrain global hemodialysisand peritoneal dialysis market growth over the forecast period.
Hemodialysis and PeritonealDialysis Market Key Players
Key players operating in theglobal hemodialysis and peritoneal dialysis market include Fresenius MedicalCare AG & Co. KGaA, DaVita Healthcare Partners, Inc., Baxter International,Inc., B. Braun Melsungen AG, Nipro Corporation, Diaverum Deutschland GmbH,Nikkiso Co. Ltd., Asahi Kasei Corporation, and NxStage Medical, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2327
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
